Sunshine Biopharma, Inc. (SBFM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 24.78M | 26.85M | 27.97M | 27.85M | 24.48M | 25.97M | 25.98M | 25.75M | 28.83M | 24.89M | 25.43M | 26.1M |
| Cash & Short-Term Investments | 6.91M | 9.12M | 9.31M | 10.31M | 8.2M | 9.69M | 12.21M | 11.51M | 17.43M | 16.29M | 18.85M | 19.73M |
| Cash Only | 6.91M | 9.12M | 9.31M | 10.31M | 8.12M | 9.69M | 12.21M | 11.51M | 17.43M | 16.29M | 18.85M | 19.73M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 70.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 4.01M | 3.46M | 4.16M | 3.59M | 3.45M | 3.87M | 3.22M | 3.97M | 2.83M | 2.55M | 2.03M | 2.01M |
| Days Sales Outstanding | 41.57 | 40.84 | 37.82 | 34 | 36.97 | 33.98 | 39.22 | 33.26 | 32.46 | 27.47 | 31.24 | 31.11 |
| Inventory | 13.17M | 13.47M | 14.06M | 13.02M | 11.86M | 11.28M | 9.82M | 8.49M | 7.7M | 5.73M | 4.52M | 4.25M |
| Days Inventory Outstanding | 200.32 | 224.3 | 196.38 | 189.04 | 168.71 | 149.27 | 151.25 | 106.03 | 117.84 | 92.25 | 101.66 | 100.39 |
| Other Current Assets | 71.74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 3.15M | 3.23M | 3.52M | 4.11M | 4.71M | 4.59M | 4.07M | 3.55M | 3.07M | 2.46M | 2.22M | 2.31M |
| Property, Plant & Equipment | 1.23M | 1.34M | 1.42M | 1.53M | 1.42M | 1.48M | 1.13M | 1.11M | 1M | 1.01M | 999.22K | 1.08M |
| Fixed Asset Turnover | 6.31x | 6.23x | 6.39x | 6.38x | 6.13x | 7.34x | 7.54x | 8.83x | 7.49x | 7.63x | 5.74x | 5.12x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.92M | 1.89M | 2.01M | 2.49M | 3.19M | 3.02M | 2.94M | 2.45M | 2.07M | 1.44M | 1.22M | 1.23M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 92.23K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 27.93M | 30.08M | 31.49M | 31.97M | 29.19M | 30.56M | 30.06M | 29.3M | 31.9M | 27.35M | 27.65M | 28.41M |
| Asset Turnover | 0.28x | 0.28x | 0.30x | 0.31x | 0.30x | 0.32x | 0.28x | 0.30x | 0.25x | 0.28x | 0.21x | 0.20x |
| Asset Growth % | -4.31% | -1.57% | 4.76% | 9.09% | -8.5% | 11.75% | 8.7% | 3.14% | 18.18% | -7.44% | -32.34% | -32.34% |
| Total Current Liabilities | 5.88M | 6.44M | 6.65M | 5.57M | 5.76M | 6.31M | 4.53M | 5.3M | 6.53M | 5.55M | 5.09M | 4.66M |
| Accounts Payable | 5.1M | 5.66M | 6.14M | 4.8M | 5.02M | 5.54M | 4.16M | 4.93M | 3.62M | 2.59M | 2.22M | 1.76M |
| Days Payables Outstanding | 80.98 | 96.13 | 79.29 | 74.64 | 77.06 | 68.63 | 75.06 | 55.97 | 54.39 | 43.25 | 46.15 | 56.7 |
| Short-Term Debt | 209.23K | 215.64K | 0 | 0 | 0 | 0 | 0 | 114.45K | 0 | 0 | 117.84K | 122.15K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 254.97K | 0 | 0 | 0 |
| Other Current Liabilities | 295.8K | 295.8K | 295.8K | 0 | 523.91K | 295.8K | 254.97K | 0 | 2.55M | 2.55M | 2.55M | 2.55M |
| Current Ratio | 4.22x | 4.17x | 4.20x | 5.00x | 4.25x | 4.11x | 5.74x | 4.86x | 4.41x | 4.48x | 5.00x | 5.60x |
| Quick Ratio | 1.98x | 2.08x | 2.09x | 2.66x | 2.19x | 2.33x | 3.57x | 3.26x | 3.23x | 3.45x | 4.11x | 4.69x |
| Cash Conversion Cycle | 160.91 | 169 | 154.91 | 148.4 | 128.62 | 114.62 | 115.41 | 83.33 | 95.9 | 76.47 | 86.74 | 74.8 |
| Total Non-Current Liabilities | 535.61K | 596.78K | 636.71K | 706.53K | 722.2K | 744.72K | 489.03K | 511.63K | 545.7K | 587.76K | 598.72K | 639.88K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 535.61K | 596.78K | 636.71K | 706.53K | 722.2K | 744.72K | 440.3K | 462.91K | 496.97K | 539.03K | 555.69K | 596.85K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.73K | 48.73K | 48.73K | 43.03K | 43.03K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 48.73K | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 6.41M | 7.04M | 7.29M | 6.28M | 6.48M | 7.06M | 5.02M | 5.81M | 7.08M | 6.14M | 5.69M | 5.3M |
| Total Debt | 744.84K | 812.42K | 854.76K | 929.03K | 936.18K | 952.48K | 556.55K | 577.36K | 612.37K | 657.71K | 673.53K | 719K |
| Net Debt | -6.17M | -8.31M | -8.45M | -9.38M | -7.19M | -8.73M | -11.65M | -10.93M | -16.82M | -15.63M | -18.17M | -19.01M |
| Debt / Equity | 0.03x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.02x | 0.02x | 0.02x | 0.03x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -267.14x | - | -3419.37x | -24.65x | -33.20x | -14.85x | -243.50x |
| Total Equity | 21.52M | 23.04M | 24.2M | 25.68M | 22.7M | 23.5M | 25.04M | 23.49M | 24.82M | 21.21M | 21.96M | 23.11M |
| Equity Growth % | -5.22% | -1.97% | -3.35% | 9.34% | -8.53% | 10.81% | 14% | 1.64% | 27.74% | -1.94% | -45.61% | -44.83% |
| Book Value per Share | 43.86 | 55.42 | 52.02 | 1142.51 | 83.99 | 91.09 | 197.47 | 4723.48 | 7739.20 | 17761.61 | 17092.20 | 182.25 |
| Total Shareholders' Equity | 21.52M | 23.04M | 24.2M | 25.68M | 22.7M | 23.5M | 25.04M | 23.49M | 24.82M | 21.21M | 21.96M | 23.11M |
| Common Stock | 4.91K | 4.91K | 4.55K | 4.55K | 2.71K | 2.58K | 2K | 1.17K | 995 | 28.02K | 25.68K | 25.75K |
| Retained Earnings | -76.26M | -75.02M | -72.87M | -71.99M | -70.22M | -69.04M | -66.88M | -65.68M | -65.19M | -63.91M | -62.66M | -62M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -343.31K | -65.31K | -320.84K | 280.79K | -803.77K | -829.96K | 168.59K | -683.05K | 152.4K | 696.11K | 204.55K | 665.06K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |